NCT00185484View on ClinicalTrials.gov

Efficacy and Safety Oral Contraceptive Study

PHASE3CompletedINTERVENTIONAL

Enrollment

1,113

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

January 31, 2006

Conditions

Contraception

Interventions

DRUG

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)

Oral administration of YAZ (0.02mg ethinyl estradiol-ß-cyclodextrin clathrate and 3mg drospirenone, 24 day hormone tablets followed by 4 days of placebo tablets for 13 cycles